Strata Critical Medical Inc Revenue Growth Rates (SRTA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Strata Critical Medical Inc   (NASDAQ: SRTA)
 

SRTA's Revenue Growth by Quarter and Year

Strata Critical Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRTA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 72.51
1st Quarter March 67.12
FY 139.63

SRTAs Annual Revenue
Strata Critical Medical Inc 's Revenue in the fiscal year 2025 $ 197.13 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2024 $ 248.69 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2023 $ 225.18 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2022 $ 146.12 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2021 $ 50.53 millions




SRTA Revenue second quarter 2026 Y/Y Growth Comment
Strata Critical Medical Inc reported Revenue growth of 2.41% year on year in the second quarter 2026, to $ 72.51 millions, this is lower than Strata Critical Medical Inc 's recent average Revenue improvement of 27.78%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue growth. While Strata Critical Medical Inc ' s Revenue increase of 2.41% ranks overall at the positon no. 2480 in the second quarter 2026.


SRTA Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -58.2 % 14.49 % 24.49 %
3rd Quarter September - -34.16 % 4.82 % 56.26 %
2nd Quarter June 2.41 % 4.19 % 11.41 % 71.18 %
1st Quarter March 23.59 % 5.44 % 13.78 % 70 %
FY   - -20.74 % 10.44 % -

Financial Statements
Strata Critical Medical Inc 's second quarter 2026 Revenue $ 72.51 millions SRTA's Income Statement
Strata Critical Medical Inc 's second quarter 2025 Revenue $ 70.80 millions Quarterly SRTA's Income Statement


SRTA Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -53.91 % -27.4 % -33.54 %
3rd Quarter September - -30.37 % 10.2 % 17.13 %
2nd Quarter June 8.02 % 30.36 % 31.92 % 34.72 %
1st Quarter March 195.42 % -0.09 % 8.49 % 18.69 %
FY (Year on Year)   - -20.74 % 10.44 % -


Back to SRTA Growth rate Comparisons >> Back to SRTA Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2480

Revenue Y/Y Growth Statistics
High Average Low
95.62 % 27.78 % -20.74 %
(Sep 30 2022)   (Dec 31 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2480
Revenue Y/Y Growth Statistics
High Average Low
95.62 % 27.78 % -20.74 %
(Sep 30 2022)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Strata Critical Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
195.4 % 16.29 % -100 %
(Mar 31 2026)  


SRTA's II. Quarter Q/Q Revenue Comment
Strata Critical Medical Inc achieved in the II. Quarter 2026 below company average Revenue increase of 8.02% quarter on quarter, to $ 72.51 millions.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Strata Critical Medical Inc 's Revenue growth quarter on quarter, overall rank is 914.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #140
Overall #914
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #140
Overall #914
Revenue Q/Q Growth Statistics
High Average Low
195.4 % 16.29 % -100 %
(Mar 31 2026)  


SRTA's II. Quarter Q/Q Revenue Comment
Strata Critical Medical Inc achieved in the II. Quarter 2026 below company average Revenue increase of 8.02% quarter on quarter, to $ 72.51 millions.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Strata Critical Medical Inc 's Revenue growth quarter on quarter, overall rank is 914.


Strata Critical Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 211.64 $ 209.94 $ 197.13 $ 228.76 $ 254.34
Y / Y Revenue Growth (TTM) -16.79 % -16.52 % -20.74 % -5.4 % 6.7 %
Year on Year Revenue Growth Overall Ranking # 1855 # 1305 # 818 # 996 # 0
Seqeuential Revenue Change (TTM) 0.81 % 6.5 % -13.83 % -10.06 % 1.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 2480 # 2006 # 1440 # 1999 # 0


Cumulative Revenue growth Comment
Strata Critical Medical Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -16.79% year on year, at Jun 30 2026 compare to the -16.52% decrease at Mar 31 2026. If the Strata Critical Medical Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $212 millions.

In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1305 to 1855.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 291
Overall # 1855

Revenue TTM Y/Y Growth Statistics
High Average Low
95.62 %
 27.78 %
-20.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2480
Cumulative Revenue growth Comment
Strata Critical Medical Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -16.79% year on year, at Jun 30 2026 compare to the -16.52% decrease at Mar 31 2026. If the Strata Critical Medical Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $212 millions.

In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1305 to 1855.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 291
Overall # 1855

Revenue TTM Y/Y Growth Statistics
High Average Low
95.62 %
27.78 %
-20.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2480




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SRTA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Orthofix Medical Inc 4.15%$ 4.147 millions
Pediatrix Medical Group Inc 4.04%$ 4.040 millions
Nrc Health3.98%$ 3.978 millions
Bioventus Inc 3.76%$ 3.757 millions
Heron Therapeutics Inc 3.64%$ 3.640 millions
Prime Medicine Inc 3.50%$ 3.498 millions
Inogen Inc 3.04%$ 3.042 millions
Pacific Health Care Organization Inc2.79%$ 2.786 millions
Quidelortho Corp2.77%$ 2.769 millions
C4 Therapeutics Inc 2.75%$ 2.754 millions
Surgery Partners Inc 2.75%$ 2.748 millions
Lantheus Holdings Inc 2.69%$ 2.690 millions
Healthcare Services Group Inc 2.69%$ 2.686 millions
Adma Biologics Inc 2.61%$ 2.613 millions
Pfizer Inc2.60%$ 2.600 millions
Infusystem Holdings Inc2.59%$ 2.586 millions
Outset Medical Inc 2.49%$ 2.488 millions
3m Company2.46%$ 2.459 millions
Strata Critical Medical Inc 2.41%$ 2.408 millions
Nature s Sunshine Products inc 2.35%$ 2.350 millions
Solventum Corporation2.22%$ 2.221 millions
Adc Therapeutics Sa2.17%$ 2.171 millions
Moderna Inc 2.11%$ 2.113 millions
Co diagnostics Inc 1.98%$ 1.977 millions
Rxsight Inc 1.66%$ 1.660 millions
Bioage Labs Inc 1.62%$ 1.617 millions


About Strata Critical Medical Inc Revenue Growth Rates (SRTA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Strata Critical Medical Inc (CIK 1779128).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-052256
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Strata Critical Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.